良性肾上腺皮质肿瘤中类固醇生成酶的DNA甲基化:对醛固酮生成腺瘤的新见解
这项横断面研究在大学医院采集良性肾上腺皮质腺瘤患者的新鲜冷冻组织(n=48,含无功能腺瘤9例、自主皮质醇分泌9例、库欣综合征17例、醛固酮生成腺瘤13例)及邻近腺瘤的肾上腺皮质(n=12),并采集配对醛固酮生成腺瘤与同期醛固酮生成细胞簇的福尔马林固定石蜡包埋标本(n=6)。结果显示醛固酮生成腺瘤中CYP11B2甲基化水平显著低于其他肾上腺组织(P<.001),CYP11B2表达与DNA甲基化整体呈负相关(ρ=-0.379;P=.003)。
要点
- 醛固酮生成腺瘤中CYP11B2甲基化水平显著低于其他肾上腺组织(P<.001)。
- CYP11B2表达与DNA甲基化整体呈负相关(ρ=-0.379;P=.003)。
- 配对标本中醛固酮生成腺瘤CYP11B2甲基化水平显著低于同期醛固酮生成细胞簇(P=.028)。
核心结论
- DNA甲基化对CYP11B2表达起调控作用,可能参与醛固酮生成腺瘤中醛固酮分泌过多。
- 醛固酮生成腺瘤中CYP11B2甲基化水平低于醛固酮生成细胞簇,可能提示通过渐进性CYP11B2去甲基化实现从醛固酮生成细胞簇向醛固酮生成腺瘤的转变。
- 相反,DNA甲基化似乎与CYP11B2以外的类固醇生成酶基因表达调控无关。
研究设计与样本
- 横断面研究,在大学医院进行。
- 收集良性肾上腺皮质腺瘤患者的新鲜冷冻组织(n=48):无功能腺瘤9例、自主皮质醇分泌9例、库欣综合征17例、醛固酮生成腺瘤(APA)13例,以及邻近APA的肾上腺皮质(n=12)。
- 收集配对的APA与同期醛固酮生成细胞簇(APCC)的福尔马林固定石蜡包埋(FFPE)标本(n=6)。
- 用定量亚硫酸氢盐下一代测序评估新鲜冷冻组织(CYP11A1、CYP11B1、CYP11B2、CYP17A1、CYP21A2、HSD3B1、HSD3B2、NR5A1、STAR和TSPO)及FFPE APA/APCC配对样本(CYP11B2)的DNA甲基化水平。
- 用定量实时聚合酶链反应检测CYP11B1、CYP11B2、CYP17、CYP21和STAR基因表达。
主要发现
- APA中CYP11B2甲基化水平显著低于其他肾上腺组织(P<.001)。
- 其余基因的甲基化水平在各组间相当。
- 整体上,CYP11B2表达与DNA甲基化呈负相关(ρ=-0.379;P=.003)。
- 在FFPE配对的APA/APCC样本中,APA的CYP11B2甲基化水平显著低于同期APCC(P=.028)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: DNA methylation has been identified among putative regulatory mechanisms for CYP11B2 expression in primary aldosteronism. OBJECTIVE: The objective of this work is to investigate DNA methylation and expression of genes encoding steroidogenic enzymes in benign adrenocortical tumors. DESIGN AND SETTING: This cross-sectional study took place at university hospitals. PATIENTS: We collected fresh-frozen tissues from patients with benign adrenocortical adenomas (n = 48) (nonfunctioning n = 9, autonomous cortisol secretion n = 9, Cushing syndrome n = 17, aldosterone-producing [APA] n = 13) and adrenal cortex adjacent to APA (n = 12). We collected formalin-fixed, paraffin-embedded (FFPE) specimens of paired APA and concurrent aldosterone-producing cell clusters (APCCs) (n = 6). INTERVENTION: DNA methylation levels were evaluated by quantitative bisulfite next-generation sequencing in fresh-frozen tissues (CYP11A1, CYP11B1, CYP11B2, CYP17A1, CYP21A2, HSD3B1, HSD3B2, NR5A1, STAR, and TSPO) and FFPE APA/APCC paired samples (CYP11B2). CYP11B1, CYP11B2, CYP17, CYP21, and STAR gene expressions were examined by quantitative real-time polymerase chain reaction. MAIN OUTCOME MEASURE: The main outcome measure was DNA methylation. RESULTS: CYP11B2 methylation levels were significantly lower in APA than in other adrenal tissues (P < .001). Methylation levels of the remaining genes were comparable among groups. Overall, CYP11B2 expression and DNA methylation were negatively correlated (ρ = -0.379; P = .003). In FFPE-paired APA/APCC samples, CYP11B2 methylation level was significantly lower in APA than in concurrent APCCs (P = .028). CONCLUSIONS: DNA methylation plays a regulatory role for CYP11B2 expression and may contribute to aldosterone hypersecretion in APA. Lower CYP11B2 methylation levels in APA than in APCCs may suggest an APCC-to-APA switch via progressive CYP11B2 demethylation. Conversely, DNA methylation seems not to be relevant in regulating the expression of genes encoding steroidogenic enzymes other than CYP11B2.
引用
- Di Dalmazi G, Morandi L, Rubin B, et al. DNA Methylation of Steroidogenic Enzymes in Benign Adrenocortical Tumors: New Insights in Aldosterone-Producing Adenomas. J Clin Endocrinol Metab. 2020. PMID: 32844182. doi:10.1210/clinem/dgaa585
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。